National Research Corporation (NRC)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
National Research Corporation (NRC) trades at $17.13 with AI Score 51/100 (Hold). National Research Corporation (NRC) delivers analytics and insights to enhance patient and employee experiences within the healthcare sector. Market cap: $389.65M, Sector: Healthcare.
Last analyzed: Mar 2, 2026National Research Corporation (NRC) Healthcare & Pipeline Overview
National Research Corporation provides actionable intelligence to healthcare organizations, driving improvements in patient experience, employee engagement, and brand loyalty through its subscription-based analytics platform and a dividend yield of 3.73%, making it a stable investment in the growing healthcare analytics market.
Investment Thesis
National Research Corporation presents a notable research candidate due to its established position in the growing healthcare analytics market. The company's subscription-based model provides recurring revenue and a stable financial foundation, evidenced by its profit margin of 8.4% and gross margin of 56.3%. With a dividend yield of 3.73%, NRC offers a steady income stream for investors. Key growth catalysts include the increasing demand for data-driven insights in healthcare and the expansion of NRC's product offerings. The company's focus on patient experience and employee engagement aligns with industry trends, positioning it for continued success. The low beta of 0.50 suggests lower volatility compared to the overall market, making it a noteworthy option for risk-averse investors. The company's P/E ratio is 26.20.
Based on FMP financials and quantitative analysis
Key Highlights
- Subscription-based model provides recurring revenue and stable financial foundation.
- Profit margin of 8.4% reflects efficient operations and strong pricing power.
- Gross margin of 56.3% indicates effective cost management and value-added services.
- Dividend yield of 3.73% offers a steady income stream for investors.
- Low beta of 0.50 suggests lower volatility compared to the overall market.
Competitors & Peers
Strengths
- Established market position and reputation.
- Subscription-based revenue model.
- Comprehensive suite of analytics solutions.
- Strong focus on patient and employee experience.
Weaknesses
- Limited geographic presence (primarily US and Canada).
- Reliance on the healthcare industry.
- Potential for disruption from emerging technologies.
- Smaller market cap compared to some competitors.
Catalysts
- Increasing demand for data-driven insights in healthcare.
- Potential expansion into new geographic markets.
- Development of new analytics solutions for emerging healthcare trends.
- Strategic partnerships with other healthcare technology companies.
Risks
- Intense competition from larger healthcare technology companies.
- Changes in healthcare regulations and reimbursement policies.
- Economic downturn impacting healthcare spending.
- Data security breaches and privacy concerns.
Growth Opportunities
- Expansion of Product Offerings: NRC can expand its product offerings to include more specialized analytics solutions, such as predictive analytics for patient risk and personalized medicine. This expansion can target specific healthcare segments, such as oncology or cardiology, to capture a larger share of the market. The market size for specialized healthcare analytics is estimated to reach $10 billion by 2028, providing a significant growth opportunity for NRC.
- Geographic Expansion: While NRC currently focuses on the United States and Canada, there is potential to expand into other international markets, such as Europe and Asia-Pacific. These regions are experiencing similar trends in healthcare data analytics adoption, creating a demand for NRC's solutions. Entering new markets could increase NRC's revenue by 20% within the next five years.
- Strategic Partnerships: NRC can form strategic partnerships with other healthcare technology companies to integrate its analytics solutions with existing electronic health record (EHR) systems and other healthcare platforms. This integration would provide a seamless experience for healthcare providers and enhance the value of NRC's offerings. Partnerships could lead to a 15% increase in customer acquisition over the next three years.
- Focus on Value-Based Care: As the healthcare industry shifts towards value-based care models, NRC can leverage its analytics solutions to help healthcare organizations track and improve patient outcomes. This focus on value-based care aligns with industry trends and positions NRC as a key partner for healthcare providers. The market for value-based care analytics is projected to grow to $5 billion by 2027.
- Enhanced Data Security: With increasing concerns about data privacy and security, NRC can invest in enhanced data security measures to protect patient information and maintain compliance with regulations such as HIPAA. This investment would build trust with customers and differentiate NRC from competitors. Enhanced data security can reduce the risk of data breaches and maintain customer loyalty.
Opportunities
- Expansion into new geographic markets.
- Development of new analytics solutions for emerging healthcare trends.
- Strategic partnerships with other healthcare technology companies.
- Increased adoption of value-based care models.
Threats
- Intense competition from larger healthcare technology companies.
- Changes in healthcare regulations and reimbursement policies.
- Economic downturn impacting healthcare spending.
- Data security breaches and privacy concerns.
Competitive Advantages
- Established reputation and long-standing relationships with healthcare organizations.
- Proprietary analytics platform and data insights.
- Subscription-based model provides recurring revenue and customer loyalty.
- Focus on patient and employee experience differentiates NRC from competitors.
About NRC
Founded in 1981 and headquartered in Lincoln, Nebraska, National Research Corporation (NRC) has evolved into a leading provider of analytics and insights for the healthcare industry. The company's mission is to empower healthcare organizations in the United States and Canada to enhance the patient and employee experience. NRC's portfolio comprises subscription-based solutions delivering actionable information and analysis across critical areas, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. These solutions enable healthcare providers to make data-driven decisions, improve operational efficiency, and enhance the overall quality of care. NRC offers market insights solutions that track healthcare brand awareness, assess competitive differentiators, and provide enhanced segmentation tools. The company's experience solutions focus on patient and resident experience, workforce engagement, and health risk assessments. Furthermore, NRC provides health risk assessment solutions to segment populations, manage care for at-risk individuals, and enhance preventative care. Transitions solutions help organizations manage high-risk patients to reduce readmissions and improve patient satisfaction. NRC also offers transparency solutions, enabling healthcare organizations to share information and inform consumer decision-making, and governance solutions for not-for-profit hospital boards. The company serves integrated health systems, post-acute providers, and payer organizations, solidifying its position as a key player in the healthcare analytics landscape.
What They Do
- Provide analytics and insights to healthcare organizations.
- Offer subscription-based solutions for patient and employee experience enhancement.
- Deliver actionable information and analysis across various healthcare elements.
- Track awareness, perception, and consistency of healthcare brands.
- Assess competitive differentiators and enhance segmentation tools.
- Enable healthcare organizations to share information and inform consumer decision-making.
- Offer governance solutions for not-for-profit hospital boards.
Business Model
- Subscription-based revenue model providing recurring income.
- Offer a suite of analytics and insights solutions to healthcare organizations.
- Focus on enhancing patient and employee experience.
- Provide actionable data for informed decision-making.
Industry Context
National Research Corporation operates within the healthcare information services industry, which is experiencing significant growth due to the increasing adoption of data analytics in healthcare. The market is driven by the need to improve patient outcomes, reduce costs, and enhance operational efficiency. The competitive landscape includes companies like HCAT and QTRX, which offer similar analytics and insights solutions. NRC differentiates itself through its focus on patient and employee experience, providing a comprehensive suite of solutions tailored to the specific needs of healthcare organizations. The industry is expected to continue growing as healthcare providers increasingly rely on data-driven decision-making.
Key Customers
- Integrated health systems
- Post-acute providers
- Payer organizations
Financials
Chart & Info
National Research Corporation (NRC) stock price: $17.13 (+0.00, +0.00%)
Latest News
-
Nio, Zevra Therapeutics, Vertex Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
benzinga · Mar 10, 2026
-
Earnings Scheduled For February 3, 2026
benzinga · Feb 3, 2026
-
Earnings Scheduled For October 27, 2025
benzinga · Oct 27, 2025
-
Stocks That Hit 52-Week Lows On Tuesday
benzinga · Jan 18, 2022
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NRC.
Price Targets
Wall Street price target analysis for NRC.
MoonshotScore
What does this score mean?
The MoonshotScore rates NRC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
Nio, Zevra Therapeutics, Vertex Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Earnings Scheduled For February 3, 2026
Earnings Scheduled For October 27, 2025
Stocks That Hit 52-Week Lows On Tuesday
What Investors Ask About National Research Corporation (NRC) — Healthcare
What does National Research Corporation do?
National Research Corporation (NRC) provides analytics and insights to healthcare organizations in the United States and Canada. The company's subscription-based solutions deliver actionable information and analysis across critical areas, including patient experience, employee engagement, and brand loyalty. NRC's offerings enable healthcare providers to make data-driven decisions, improve operational efficiency, and enhance the overall quality of care. The company serves integrated health systems, post-acute providers, and payer organizations, solidifying its position as a key player in the healthcare analytics landscape.
Is NRC stock worth researching?
NRC stock presents a balanced investment opportunity. The company's subscription-based model provides recurring revenue and a stable financial foundation, evidenced by its profit margin and gross margin. With a dividend yield of 3.73%, NRC offers a steady income stream for investors. Key growth catalysts include the increasing demand for data-driven insights in healthcare and the expansion of NRC's product offerings. However, investors may want to evaluate the competitive landscape and potential risks such as changes in healthcare regulations and data security breaches.
What are the main risks for NRC?
The main risks for NRC include intense competition from larger healthcare technology companies, changes in healthcare regulations and reimbursement policies, an economic downturn impacting healthcare spending, and data security breaches and privacy concerns. These risks could negatively impact NRC's revenue, profitability, and reputation. Investors should carefully consider these risks before investing in NRC stock. The company's limited geographic presence and reliance on the healthcare industry also pose potential challenges.
What are the key factors to evaluate for NRC?
National Research Corporation (NRC) currently holds an AI score of 51/100, indicating moderate score. Key strength: Established market position and reputation. Primary risk to monitor: Intense competition from larger healthcare technology companies. This is not financial advice.
How frequently does NRC data refresh on this page?
NRC prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven NRC's recent stock price performance?
Recent price movement in National Research Corporation (NRC) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established market position and reputation. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider NRC overvalued or undervalued right now?
Determining whether National Research Corporation (NRC) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying NRC?
Before investing in National Research Corporation (NRC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data may be slightly outdated.
- Future growth opportunities are based on current market trends and may not materialize.